Lipid profile and blood glucose in patients with Diabetes Mellitus treated with Cinnamon - Systematic Review and Meta-analysis with randomized clinical research
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/18203 |
Resumo: | This study aimed to measure the efficiency of cinnamon in patients with Type 2 Diabetes Mellitus (DM2), comparing fasting plasma glucose averages and lipid profiles with a placebo group through a meta-analysis. Four databases were the source of the research to find the articles used, including: Medline / PubMed, LILACS and NCBI. 11 randomized clinical trials that evaluated cinnamon on glycemic and lipid parameters were included in this study. Meta-analysis was performed with the aid of the STATA® 16.0 software, which determined the difference in glucose means and lipid profiles compared to a placebo group. Cinnamon at concentrations of 250 mg twice a day decreased blood glucose with MD = -0.25 (95%CI = - 0.36 to -0.14; p<0.00001) and in the intervention with 2 g 3 times a day with MD = -5.60 (95%CI = -6.98 to -4.22; p<0.00001). Total cholesterol was significant with 2 g 3 times a day with MD = 0.98 (95%CI = -1.27 to -0.69), followed by LDL-cholesterol MD = 0.64 (95%CI = 0.88 to 0.40; p<0.00001), and HDL-cholesterol with 500 mg 3 times daily with MD = 0.12 (95%CI = 0.05 to 0.19). High-dose supplementation of cinnamon can reduce glucose and lipid profiles in patients with DM2. This supporting treatment can be useful when added to the diet plan of patients with DM2. |
id |
UNIFEI_a00508a31903cf3a471a2053bd0c54d9 |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/18203 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
Lipid profile and blood glucose in patients with Diabetes Mellitus treated with Cinnamon - Systematic Review and Meta-analysis with randomized clinical researchPerfil lipídico y glucemia en pacientes con diabetes mellitus tratados con canela - Revisión sistemática y metaanálisis con ensayos clínicos aleatorizadosPerfil lipídico e glicemia em portadores de Diabetes Mellitus tratados com Canela – Revisão Sistemática e Meta-análise com pesquisas clínicas randomizadasType 2 diabetes mellitusCinnamonBlood glucoseLipid profiles.Diabetes Mellitus tipo 2CanelaGlucosaPerfiles lipídicos.Diabete Mellitus tipo 2CanelaGlicemiaPerfis lipídicos.This study aimed to measure the efficiency of cinnamon in patients with Type 2 Diabetes Mellitus (DM2), comparing fasting plasma glucose averages and lipid profiles with a placebo group through a meta-analysis. Four databases were the source of the research to find the articles used, including: Medline / PubMed, LILACS and NCBI. 11 randomized clinical trials that evaluated cinnamon on glycemic and lipid parameters were included in this study. Meta-analysis was performed with the aid of the STATA® 16.0 software, which determined the difference in glucose means and lipid profiles compared to a placebo group. Cinnamon at concentrations of 250 mg twice a day decreased blood glucose with MD = -0.25 (95%CI = - 0.36 to -0.14; p<0.00001) and in the intervention with 2 g 3 times a day with MD = -5.60 (95%CI = -6.98 to -4.22; p<0.00001). Total cholesterol was significant with 2 g 3 times a day with MD = 0.98 (95%CI = -1.27 to -0.69), followed by LDL-cholesterol MD = 0.64 (95%CI = 0.88 to 0.40; p<0.00001), and HDL-cholesterol with 500 mg 3 times daily with MD = 0.12 (95%CI = 0.05 to 0.19). High-dose supplementation of cinnamon can reduce glucose and lipid profiles in patients with DM2. This supporting treatment can be useful when added to the diet plan of patients with DM2.Este estudio tuvo como objetivo medir la eficacia de la canela en pacientes con Diabetes Mellitus tipo 2 (DM2), comparando los perfiles medios de glucosa plasmática y lípidos en ayunas con un grupo de placebo a través de un metanálisis. Cuatro bases de datos fueron la fuente de investigación para los hallazgos de los artículos utilizados, incluyendo: Medline / PubMed, LILACS y NCBI. En este estudio se incluyeron 11 ensayos controlados aleatorios que evaluaron la canela en parámetros glucémicos y lipídicos. El metanálisis se realizó con la ayuda del software STATA® 16.0, que determinó la diferencia en los perfiles medios de glucosa y lípidos en comparación con un grupo de placebo. La canela a concentraciones de 250 mg dos veces al día disminuyó la glucosa en sangre con MD = -0,25 (IC del 95% = -0,36 a -0,14; p <0,00001) y en la intervención con 2 g 3 veces al día al día con MD = -5,60 (IC del 95% = -6,98 a -4,22; p<0,00001). El colesterol total fue significativo con 2 g 3 veces al día con MD = 0,98 (IC del 95% = -1,27 a -0,69), seguido de MD de colesterol LDL = 0,64 (IC del 95% = 0,88 a 0,40; p <0,00001), y Colesterol HDL con 500 mg 3 veces al día con MD = 0,12 (IC del 95% = 0,05 a 0,19). La suplementación con altas dosis de canela puede reducir los perfiles de glucosa y lípidos en sangre en pacientes con DM2. Este puede ser un tratamiento coadyuvante útil cuando se agrega al plan de alimentación de los pacientes con DM2.Esse presente estudo teve como finalidade mensurar a eficiência da canela em portadores de Diabetes Mellitus tipo 2 (DM2), comparando as médias de glicose no plasma em jejum e os perfis lipídicos com um grupo placebo através de uma Metanálise. Quatro bancos de dados foram fonte das pesquisas para achados dos artigos utilizados, incluindo: Medline/PubMed, LILACS e NCBI. 11 ensaios clínicos randomizados que avaliaram a canela nos parâmetros glicêmicos e lipídicos, foram incluídos nesse estudo. A Metanálise foi realizada com o auxílio do software STATA® 16.0, que determinou a diferença das médias de glicose e perfis lipídicos comparando com um grupo placebo. A canela nas concentrações de 250 mg 2 vezes ao dia diminuiu a glicemia com MD= -0,25 (IC95% = - 0,36 a -0,14; p<0,00001) e na intervenção com 2 g 3 vezes ao dia com MD= -5,60 (IC95% = -6,98 a -4,22; p<0,00001). Colesterol total obteve significância com 2 g 3 vezes ao dia com MD = 0,98 (IC95% = -1,27 a -0,69), seguido do LDL-colesterol MD = 0,64 (IC95% = 0,88 a 0,40; p<0,00001), e HDL-colesterol com 500 mg 3 vezes ao dia com MD = 0,12 (IC95% = 0,05 a 0,19). A suplementação com altas doses de canela pode reduzir a glicemia e os perfis lipídicos em pacientes com DM2. Esse pode ser um tratamento coadjuvante útil quando adicionado ao plano alimentar de pacientes com DM2.Research, Society and Development2021-07-31info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/1820310.33448/rsd-v10i9.18203Research, Society and Development; Vol. 10 No. 9; e45910918203Research, Society and Development; Vol. 10 Núm. 9; e45910918203Research, Society and Development; v. 10 n. 9; e459109182032525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIenghttps://rsdjournal.org/index.php/rsd/article/view/18203/16355Copyright (c) 2021 Antônio Guilherme Sousa Silva; Lucas Cândido Gonçalves; Paulo Alex Neves da Silva; Lilian Carla Carneiro; José Arthur Silva e Sousa; Fábio Silvestre Ataídes; Xisto Sena Passos; Antonio Márcio Teodoro Cordeiro Silva; Yara Lúcia Marques Maiahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessSilva, Antônio Guilherme SousaGonçalves, Lucas CândidoSilva, Paulo Alex Neves daCarneiro, Lilian CarlaSousa, José Arthur Silva eAtaídes, Fábio SilvestrePassos, Xisto SenaSilva, Antonio Márcio Teodoro CordeiroMaia, Yara Lúcia Marques2021-09-12T14:28:06Zoai:ojs.pkp.sfu.ca:article/18203Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:38:23.219388Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
Lipid profile and blood glucose in patients with Diabetes Mellitus treated with Cinnamon - Systematic Review and Meta-analysis with randomized clinical research Perfil lipídico y glucemia en pacientes con diabetes mellitus tratados con canela - Revisión sistemática y metaanálisis con ensayos clínicos aleatorizados Perfil lipídico e glicemia em portadores de Diabetes Mellitus tratados com Canela – Revisão Sistemática e Meta-análise com pesquisas clínicas randomizadas |
title |
Lipid profile and blood glucose in patients with Diabetes Mellitus treated with Cinnamon - Systematic Review and Meta-analysis with randomized clinical research |
spellingShingle |
Lipid profile and blood glucose in patients with Diabetes Mellitus treated with Cinnamon - Systematic Review and Meta-analysis with randomized clinical research Silva, Antônio Guilherme Sousa Type 2 diabetes mellitus Cinnamon Blood glucose Lipid profiles. Diabetes Mellitus tipo 2 Canela Glucosa Perfiles lipídicos. Diabete Mellitus tipo 2 Canela Glicemia Perfis lipídicos. |
title_short |
Lipid profile and blood glucose in patients with Diabetes Mellitus treated with Cinnamon - Systematic Review and Meta-analysis with randomized clinical research |
title_full |
Lipid profile and blood glucose in patients with Diabetes Mellitus treated with Cinnamon - Systematic Review and Meta-analysis with randomized clinical research |
title_fullStr |
Lipid profile and blood glucose in patients with Diabetes Mellitus treated with Cinnamon - Systematic Review and Meta-analysis with randomized clinical research |
title_full_unstemmed |
Lipid profile and blood glucose in patients with Diabetes Mellitus treated with Cinnamon - Systematic Review and Meta-analysis with randomized clinical research |
title_sort |
Lipid profile and blood glucose in patients with Diabetes Mellitus treated with Cinnamon - Systematic Review and Meta-analysis with randomized clinical research |
author |
Silva, Antônio Guilherme Sousa |
author_facet |
Silva, Antônio Guilherme Sousa Gonçalves, Lucas Cândido Silva, Paulo Alex Neves da Carneiro, Lilian Carla Sousa, José Arthur Silva e Ataídes, Fábio Silvestre Passos, Xisto Sena Silva, Antonio Márcio Teodoro Cordeiro Maia, Yara Lúcia Marques |
author_role |
author |
author2 |
Gonçalves, Lucas Cândido Silva, Paulo Alex Neves da Carneiro, Lilian Carla Sousa, José Arthur Silva e Ataídes, Fábio Silvestre Passos, Xisto Sena Silva, Antonio Márcio Teodoro Cordeiro Maia, Yara Lúcia Marques |
author2_role |
author author author author author author author author |
dc.contributor.author.fl_str_mv |
Silva, Antônio Guilherme Sousa Gonçalves, Lucas Cândido Silva, Paulo Alex Neves da Carneiro, Lilian Carla Sousa, José Arthur Silva e Ataídes, Fábio Silvestre Passos, Xisto Sena Silva, Antonio Márcio Teodoro Cordeiro Maia, Yara Lúcia Marques |
dc.subject.por.fl_str_mv |
Type 2 diabetes mellitus Cinnamon Blood glucose Lipid profiles. Diabetes Mellitus tipo 2 Canela Glucosa Perfiles lipídicos. Diabete Mellitus tipo 2 Canela Glicemia Perfis lipídicos. |
topic |
Type 2 diabetes mellitus Cinnamon Blood glucose Lipid profiles. Diabetes Mellitus tipo 2 Canela Glucosa Perfiles lipídicos. Diabete Mellitus tipo 2 Canela Glicemia Perfis lipídicos. |
description |
This study aimed to measure the efficiency of cinnamon in patients with Type 2 Diabetes Mellitus (DM2), comparing fasting plasma glucose averages and lipid profiles with a placebo group through a meta-analysis. Four databases were the source of the research to find the articles used, including: Medline / PubMed, LILACS and NCBI. 11 randomized clinical trials that evaluated cinnamon on glycemic and lipid parameters were included in this study. Meta-analysis was performed with the aid of the STATA® 16.0 software, which determined the difference in glucose means and lipid profiles compared to a placebo group. Cinnamon at concentrations of 250 mg twice a day decreased blood glucose with MD = -0.25 (95%CI = - 0.36 to -0.14; p<0.00001) and in the intervention with 2 g 3 times a day with MD = -5.60 (95%CI = -6.98 to -4.22; p<0.00001). Total cholesterol was significant with 2 g 3 times a day with MD = 0.98 (95%CI = -1.27 to -0.69), followed by LDL-cholesterol MD = 0.64 (95%CI = 0.88 to 0.40; p<0.00001), and HDL-cholesterol with 500 mg 3 times daily with MD = 0.12 (95%CI = 0.05 to 0.19). High-dose supplementation of cinnamon can reduce glucose and lipid profiles in patients with DM2. This supporting treatment can be useful when added to the diet plan of patients with DM2. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-07-31 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/18203 10.33448/rsd-v10i9.18203 |
url |
https://rsdjournal.org/index.php/rsd/article/view/18203 |
identifier_str_mv |
10.33448/rsd-v10i9.18203 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/18203/16355 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 10 No. 9; e45910918203 Research, Society and Development; Vol. 10 Núm. 9; e45910918203 Research, Society and Development; v. 10 n. 9; e45910918203 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052684541362176 |